AllPennyStocks.com

Teaching Investors How To Turn Pennies Into Dollars TM



Advertising    Contact Us
Welcome, Guest Login / Sign-Up
Navigation menu
 

Featured Link

 

Add Us to favorites

Click Here Now!
or hit CRL+D

 

Search Web Site

 

 

Canadian Company Spotlight


 

Asantae Holdings International Inc. Website: Click Here

Information As Of March 7, 2012

Exchange: TSX-Venture Market Cap: 4.47 Million
Outstanding Shares: 24.8 Million 52 Low / High: $0.09 / $0.44

Price March 7, 2012: $0.18

JVA Recent Stock Quote and News: Click Here

"Asantae has several products in addition to RealW8 and is looking to top its record revenue of more than $4 million in 2010 with the goal of being cash-flow positive in Q2 2012."


Overview

Asantae Holdings International Inc. is a producer and marketer of innovative nutritional products through a network of independent distributors (Asantae Independent Affiliates). Asantae's flagship product RealW8™ addresses the primary threat to public health in the industrialized world; overweight and obesity. Asantae's approach to this threat is based on a body of research related to the brain chemistry of addiction, chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (obesity, heart disease, diabetes, stroke, some cancers, etc.).


Investment Highlights

  • Solution for Epidemic. Asantae’s RealW8™ offers a core solution to obesity, a health challenge that affects 1 in 3 adults and 1 in 6 children in the U.S. and leads to numerous health consequences and diminished quality of life.
  • Designed by Cardiovascular Surgeon. RealW8 was designed under the guidance of Dr. Dwight Lundell, a cardiovascular surgeon and father of Asantae founder and Chief Executive Officer, Dan Lundell.
  • Targets Core Issues of Obesity. The all-natural product is the first weight-loss supplement to address the main catalyst of weight gain and excess fat storage - our craving for and overindulgence of simple carbohydrates and sugar.
  • Massive Industries. The weight loss industry is $60 billion and growing. Asantae is looking to maximize its capture of that industry by leveraging the $114 billion Network Marketing industry that employs about 16 million people in the United States and garnered investors like Warren Buffet and Donald Trump.
  • Orders & Distributors Rising. Asantae’s lead distributor has a proven track record in weight loss and network marketing. At the last company he lead, his efforts created nearly $500 million in sales of weight loss products. Asantae has more than doubled its list of active distributors during the months of September to December 2011. The strategy is working as shown through the fact that auto-ship orders have skyrocketed by 400 percent over pre-launch levels.
  • Unmatched Executives. The team at Asantae is comprised of seasoned professionals with over 150 years of experience in the Health and Nutrition Industry. The Board of Directors includes the Chairman of the Board, Honorable John Reynolds, who is the Former Official Opposition House Leader for the Conservative Caucus in Canada. Honorable Larry Campbell, a Member of the Senate of Canada and former mayor of Vancouver, sits as a director at Asantae.
  • Room for Exponential Growth. Asantae has minimal debt, less than 25 million shares outstanding and a paltry market cap of $4.47 million, giving it unprecedented room for possible share appreciation.

Profile

The world is packing on pounds. That’s not a harsh statement or meant to ridicule; it’s a hard fact and one that we as a planet need to spend more time addressing. Why this is happening is a topic for lengthy and complicated debate as the list of macro and micro reasons ranges from genetic to economic to psychological factors and everything in between. The positive thing is that obesity is garnering more attention today than it ever has before because of the life-threatening complications that research has identified as firmly correlated to excessive amounts of body fat.

The World Health Organization considers a person obese if they have a BMI (Body Mass Index) score of 30 or over, and overweight if they have a score of between 25 and 30. Obesity rates in the United States have been on the rise for two decades and currently cost the country approximately $150 billion annually, or 10 percent of all medical costs. The obesity rate has reached epidemic levels with 1 in 3 adults and 1 in 6 children considered obese in the U.S.

People suffering from obesity are at greatly increased odds to develop heart disease, cancer and Type-2 diabetes. Is that simple statement not scary enough? Consider these facts: Cardiovascular disease (CVD) is the number one cause of death globally with 17.3 million people dying from CVDs in 2008 (30% of all deaths) and that number is expected to surge to 23.6 million by 2030; 25% of all deaths in the United States are the result of cancer with nearly 600,000 people expected to die from cancer in 2011 (that’s about 1,600 people per day); and Type-2 diabetes is running rampant with the International Type-2 diabetes Federation recently stating that 10% of the global population (that’s 500 million people) will suffer from Type-2 diabetes by 2030. Obese people run higher risks in each category individually, not to mention the intermingling of likelihood of death that stems from combing each deadly disease with another one.

While the chain of events surrounding Type-2 diabetes and obesity is still somewhat spotty as to which causes which, there is no denying that obesity is probably the most important factor in the development of insulin resistance. It is also known that persons with Type-2 diabetes and people that are obese stand higher chances of pancreatic cancer. Controlling sugar spikes can help with the overall conditions and potential deadly complications. Biologically speaking, spikes in blood sugar tell the pancreas to release more insulin (Type-2 diabetes patients either do not produce insulin, not enough insulin or the body uses it improperly when produced), a hormone that regulates the absorption of sugar into the body’s cells. The increased insulin because of the high glycemic levels (blood sugar) results in the pancreas telling the liver to store the sugar as fat for later energy use, which may indeed not even be necessary; contributing to excess body fat. Completing the weight-gain cycle, fat cannot be burned for energy in the presence of elevated insulin levels. It’s a vicious cycle that starts with sugar and carbohydrates and ends with fat.

Even outside of the realm of Type-2 diabetes, repeated spikes in the blood sugar over a sustained period of time can cause major damage to the pancreas and other parts of the body by inhibiting brain functions and cause severe high blood pressure, circulatory, heart, kidney and vision problems. As such, it’s important for all people, whether affected by Type-2 diabetes or not, to regularly control sugar spikes.

In most diet discussions, controlling carbohydrates is a frequent topic of high importance. This is because in food science, the term carbohydrate generally means any food that is particularly rich in the complex carbohydrate starch (such as cereals, bread, and pasta) or simple carbohydrates, such as sugar (found in candy, jams, and desserts).

The dire need for treatments of obesity has had many biotechs chasing development and FDA approval of a drug for decades. The problem is that all efforts for new compounds have been accompanied with toxic side effects or relatively limited benefits compared to the side effects. Qnexa , an obesity drug by Vivus, Inc. (Nasdaq:VVUS) recently received approval from an FDA advisory panel after previously denying the application because of risks of birth defects and heart problems. Qnexa is a cocktail of two older drugs, phenteramine and topramine, an anti-seizure drug. The drug is already a target of significant scrutiny because it is a desperate measure to finally get an obesity drug to market that will be severely restricted in use because of side effects. Moreover, Qnexa only yielded results showing 10% weight loss after two years of intense treatment. Ultimately, Qnexa will make Vivus money, but still does not address the basic reasons for weight gain.

There is nothing more reliable in weight loss and health than exercise and diet. Just like quitting smoking, there isn’t a miracle cure, but the combination of smoking cessation products and willpower have proven far more effective than any drug on Earth. Taking the approach of science and reality to the next level has resulted in a revolutionary product by Asantae Holdings International Inc. (TSX-Venture: JVA) (Pink Sheets: ASNHF), a Phoenix, Arizona based producer and marketer of innovative nutritional products through a network of independent affiliates. The company’s flagship product is RealW8™, the first weight-loss supplement to address the main catalyst of weight gain and excess fat storage - our craving for and overindulgence of carbohydrates and sugar. RealW8 has already gone through a soft launch in the fourth quarter of 2011 to grab some traction and is ready for a full-blown launch this quarter. Do to its composition and benefits that target root causes of obesity, RealW8 looks ready to take the dietary supplement industry by storm.

The supplement was designed under the guidance of Dr. Dwight Lundell, a cardiovascular surgeon and father of Asantae founder and Chief Executive Officer Dan Lundell. Dr. Lundell can be attributed for extending the lives of countless people through performing thousands of heart by-pass surgeries, but felt that treating the symptoms was not the answer. Addressing the fundamental problems was the answer, which ultimately led to the RealW8 product. Dan Lundell's passion for Asantae's mission stems from his experience running a weight-loss clinic with his father.

In what could be called “Willpower in a Bottle,” RealW8 is a first-in-class, all-natural supplement that blunts sugar spikes and breaks the carbohydrate addition cycle by reducing cravings for carbs, some of the largest contributors to weight gain today. The supplement is comprised of a proprietary blend of a marine macroalgae extract that is designed to block the digestion of sugar and fat; nopal cactus that reduces absorption of sugars and fats in the gastrointestinal tract; and a raw organic coffee extract that has been shown to change glucose metabolism. Two capsules of RealW8 contain less caffeine that a large cup of Starbucks coffee.

While the primary focus of Asantae at the moment is centered on the hard launch of RealW8, the company also has Asantae Java™, an antioxidant coffee; Heartshot™, a supplement that reduces inflammation; and Amune™, an immune system enhancer in its portfolio of products.

Asantae is well-positioned in the $60 billion weight loss industry all by itself, but their strategies to expedite growth could send the RealW8 product “viral” across the world. The company is taking the unique marketing approach of “Network Marketing” to build brand awareness and loyalty. Network, or Multi-Level, Marketing in a $114 billion industry that has about 16 million people in the United States working under its umbrella. Household names such as Warren Buffet and Donald Trump have invested in companies that incorporate Network Marketing into their business plans. In today’s tough economic climate, the Network Marketing has even greater appeal as it has no overhead and can create residual income for people of all ages.

Asantae’s lead distributor has a proven track record in weight loss and network marketing. At the last company he lead, his efforts created nearly $500 million in sales of weight loss products. Asantae has more than doubled its list of active distributors during the months of September to December 2011. The strategy is working as shown through the fact that auto-ship orders have skyrocketed by 400 percent over pre-launch levels. In addition, the Company has a five-month trend showing a 20% - 25% affiliate growth rate per month.

Asantae is by no means unaccustomed to generating revenue. In 2010, revenues tallied just over $4 million. With the alignment of affiliate programs, the new order flow and incentive programs, the company intends to smash those record revenue levels from 2010 this year and be cash-flow positive in the second quarter of 2012.

The team at Asantae is impressive and comprised of seasoned professionals with over 150 years of experience in the Health and Nutrition Industry. In addition to CEO Dan Lundell, the Board of Directors includes the Chairman of the Board, Honorable John Reynolds, who is the Former Official Opposition House Leader for the Conservative Caucus in Canada. Honorable Larry Campbell, a Member of the Senate of Canada and former mayor of Vancouver, sits as a director at Asantae.

Technically speaking, the Asantae chart is in a prime position. The short-term moving averages, including the 20 day simple moving average is breaking upward through the 50 day simple moving average. Shorter dma’s climbing through longer dma’s is a sign of bullishness. The price per share has been channeling between 10 and 15 cents for several months, but recently made a strong move through the $0.15 resistance and is now holding that mark as support, another strong technical sign for possible upward movement. Mild resistance comes in at 19 and 23 cents, but stronger resistance doesn’t enter the picture until more than a 50 percent climb to reach $0.28.

The Relative Strength Index (RSI), a measure of momentum, is holding over 50 and has been in a multi-month uptrend. Again, this is a sign of strength in the chart. Technical traders will be looking for the momentum to continue and push through 70, or into “the power zone”.

The MACD, a gauge of trend, has been in a solid uptrend and now has made the all-important climb into positive territory by moving above the zero line. The zero mark is often referred to as “the money line” because it is a sign of bullishness that is usually accompanied by a rise in price per share. Today's close at $0.18 late in the trading day to close up 20% on volume of under 200,000 shows the moves this stock can make on minimal volume.

With resistance being indicated at around $0.15 a share, stop losses just below that level may be wise moves to protect against unwanted downside pressure. As we always mention at this point, these are merely the interpretations of AllPennyStocks.com. We encourage all investors to do their own due diligence and consult with a financial advisor prior to making any investment decisions.

With the technicals looking quite promising and the Company producing strong sales and record revenues, those metrics alone produce a winning combination, but an after the bell announcement may further fuel the uptrend that this stock is currently experiencing.

The Company announced after the bell today their corporate outlook for 2012. The Company has done a lot in a short amount of time, and this PR is further evidence of that. In the press release, Asantae CEO, Dan Lundell stated, "In January, after a better than expected pre-launch, the company began the highly anticipated official launch of RealW8™. We are extremely pleased with the metrics to date. Based on the current growth trajectory, we anticipate a significant increase in revenues and expect to be cash flow positive in the second quarter of this year; we also expect record revenues for fiscal 2012."

While the press release didn't hit on too many new points then were already public, it does indicate how quickly this Company is growing and really makes one wonder how a Company making revenues in the Millions and growing at break-neck speeds can still have a market cap of under $5 Million. However with the recent uptrend in the stock price, this market cap may not stay this low for too much longer.

Asantae is slipping under the radar of the general investment community and is only carrying a market cap of $4.47 million and a 18-cent price tag as a result; leaving considerable headroom for share appreciation. With less than 25 million shares outstanding and a minimal debt load, if the company can continue to set revenue records in 2012 and be cash-flow positive, it will present one of those rare opportunities for investors to catch a company whose ratio of market cap to revenues are inverted as an accurate reflection of future sales. A successful weight loss supplement the caliber of RealW8 should be able to take its fair market share of the multi-billion dollar industry and significantly bolster Asantae’s share price. It is for these reasons, as well as the ones listed above that we at AllPennyStocks.com have decided to turn our latest corporate spotlight on Asantae Holdings International Inc. (TSX-Venture: JVA) (Pink Sheets: ASNHF) and encourage our members to immediately begin their due diligence and add it to their watchlists.


Recent News and Press Releases
 

Asantae Provides 2012 Outlook
CNW Group (Wed, Mar 7)

 

Asantae Provides 2011 Review and Update
CNW Group (Wed, Feb 29)


Asantae to Exhibit & Present at the 2012 International Asian Investment Forum
CNW Group (Wed, Feb 22)


Asantae Announces Introduction of New Branding and Asantae Booth at Parker Seminars Tradeshow
CNW Group (Tue, Jan 17)


Asantae Announces a New Website, Affiliate Back Office and Compensation Plan
Marketwire (Mon, Dec 5)


Asantae Announces Closing of First Tranche of Non-Brokered Private Placement
Marketwire (Fri, Dec 2)


Asantae to Present at the 4th Annual LD MICRO Growth Conference
Marketwire (Thu, Dec 1)


Asantae Announces Private Placement and Debt Settlements
Marketwire (Wed, Nov 16)


Asantae Announces Pre Launch Sales of RealW8
Marketwire (Mon, Nov 7)


Asantae Holdings International Inc. Announces Appointment of Dan Lundell to Its Board of Directors
Marketwire (Tue, Nov 1)


Asantae Announces Closing of First Tranche of Non-Brokered Private Placement
Marketwire (Wed, Sep 14)


Management

DAN LUNDELL - CHIEF EXECUTIVE OFFICER

As one of the company founders and key operators, Mr. Lundell is intimately familiar with every aspect of the business. He has been a vital part of the company's 2012 strategic growth initiative 'Asantae 2.0'. His leadership inside the company has fostered a loyal and dedicated team committed to the company's growth and successful achievement of its goals. His leadership in the capital markets has lent confidence and credibility to the company's message though some of the most challenging market conditions in recent memory. Mr. Lundell's entrepreneurial background is in IT sales and management, marketing and branding, and medical practice management. Mr. Lundell's passion for Asantae's mission stems from his experience running a weight loss clinic with his father Dr. Dwight Lundell.

PAMELA EGAN, CMA - CHIEF FINANCIAL OFFICER

Pam is experienced in the financial management and regulatory compliance of dynamic organizations across Canada, private and public, with extensive experience in building financial systems and controls in high-tech, telecommunication, mineral exploration and life science industries. She currently provides financial and operational management consulting services to Brocade Metals Corp., Amato Exploration Ltd. and Superna Life Sciences Inc. and has held financial roles with Protox Therapeutics Inc., RADARSAT International Inc. and CUC Broadcasting Ltd. (now Shaw Communications). Pam is a graduate of the University of Waterloo where she received her Bachelor of Arts in Economics in 1987 and has held the designation of Certified Management Accountant since 1992.


Contact

Asantae Holdings International Inc.

Dan Lundell, CEO/COO
danlundell@asantae.com
10153 E Hampton Ave, Ste 101, Mesa, AZ, 85209 USA
Phone: 480-278-8712 / Fax: 480-383-6147

IR Contact:

Sequoia Partners Inc.
James Beesley
james@sequoiapartners.ca
Phone: 778-389-7715

or

Adam Rabiner
adamr@sequoiapartners.ca
Phone: 604-868-7881


FORWARD LOOKING STATEMENTS

This report includes forward-looking statements that reflect Asantae Holdings International Inc. current expectations about its future results, performance, prospects and opportunities. Asantae Holdings International Inc. has tried to identify these forward-looking statements by using words and phrases such as "may," "will," "expects," "anticipates," "believes," "intends," "estimates," "plan," "should," "typical," "preliminary," "we are confident" or similar expressions. These forward-looking statements are based on information currently available and are subject to a number of risks, uncertainties and other factors that could cause Asantae Holdings International Inc.'s actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and other factors include, without limitation, the Company's growth expectations and ongoing funding requirements, and specifically, the Company's growth prospects with scalable customers, and those outlined above. Other risks include the Company's limited operating history, the Company's history of operating losses, consumers' acceptance, the Company's use of licensed technologies, risk of increased competition, the potential need for additional financing, the terms and conditions of any financing that is consummated, the limited trading market for the Company's securities, the possible volatility of the Company's stock price, the concentration of ownership, and the potential fluctuation in the Company's operating results.


Disclaimer

AllPennyStocks.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. This is an advertisement for Asantae Holdings International Inc. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

© 1999-2012 AllPennyStocks.com. All rights reserved. AllPennyStocks.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. AllPennyStocks.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), AllPennyStocks.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the AllPennyStocks.com web site. AllPennyStocks.com has been compensated eight thousand dollars by the Company for its efforts in presenting the V.JVA profile on its web site and distributing it to its database of subscribers as well as other services. AllPennyStocks.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. As of the profile date, twelve thousand shares have been sold. Information presented on our web site and within our reports contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects’”, “will,” “anticipates,” “estimates, “believes,” or that by statements indicating certain actions “may,” “could,” or “might” occur.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.

 

 


 

AllPennyStocks.com © 1999 - 2014. AllPennyStocks.com is a web publishing venture produced by AllPennyStocks.com Media, Inc.